In-Person Access Only | 7.50 CE/CME Credits & MOC Points
Please read: All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com
The 11th Annual West Oncology Conference serves as a valuable forum for presenting and discussing new research findings in oncology education.
Learners are provided updates on practice-changing data in breast cancers, genitourinary cancers, hematological malignancies, gastrointestinal cancers, and lung cancers – all in a practical and interactive format, fostering discussion and impacting patient clinical outcomes. This accredited meeting is an in-person conference with on-demand access for registered attendees.
Conference Agenda Saturday, May 16, 2026
8:00 AM
Coffee and Exhibits
8:30 AM
Program Chair Welcome
8:40 AM
Updates in Gastrointestinal Cancer
Deepak Bhamidipati, MD | Sarah Cannon Research Institute
9:20 AM
Panel Discussion and Q&A - Gastrointestinal Cancer
Paxton Dickson, MD, FACS (Moderator) | University of Tennessee Health Science Center
Deepak Bhamidipati, MD | Sarah Cannon Research Institute
Holger Gieschen, MD | West Cancer Center
9:50 AM
Updates in Small Cell Lung Cancer
Jason Porter, MD | West Cancer Center
10:10 AM
Updates in Non Small Cell Lung Cancer
Ramakrishna Battini, MD | West Cancer Center
10:35 AM
Panel Discussion and Q&A - Lung Cancer
Ramakrishna Battini, MD (Moderator) | West Cancer Center
Jason Porter, MD | West Cancer Center
Yuefeng Wang, MD, PhD | West Cancer Center
11:00 AM
Breakfast and Exhibits
11:15 AM
Non-CME Breakfast - Taiho - LONSURF + bevacizumab for the Treatment of 3L Metastatic Colorectal Cancer
Saurin Chokshi, MD | The University of Tennessee Health Science Center
12:00 PM
MRD as an Endpoint in Multiple Myeloma
12:20 PM
AML and Molecular Targets with MRD Testing Alice Mims, MD, MSCR | The Ohio State University
12:40 PM
Preparing a Patient for CAR-T - Guidance to Community Oncologists
Bryan Huber, MD | Intermountain Health
1:00 PM
Panel Discussion and Q&A - Hematological Malignancies
Jason Chandler, MD (Moderator) | West Cancer Center
Alice Mims, MD, MSCR | The Ohio State University
Bryan Huber, MD | Intermountain Health
1:30 PM
Lunch and Exhibits
1:45 PM
Non-CME Lunch - Natera - Signatera: ctDNA MRD in Lymphoma
Heather Youngberg | Natera
2:30 PM
Housekeeping and Survey
2:40 PM
Solid Tumor Molecular Board Panel
Ari VanderWalde, MD (Moderator) | West Cancer Center
Tom Corbiere, PhD | Caris Life Sciences
Jason Porter, MD | Guardant Health
George Daneker, Jr. MD | Natera
t
3:10 PM
Liquid Tumor Molecular Board Panel
Jason Chandler, MD (Moderator) | West Cancer Center
Alice Mims, MD, MSCR | The Ohio State University
Bryan Huber, MD | Intermountain Health
Farah Abdulla, MD | Caris Life Sciences
3:40 PM
Networking Reception
4:40 PM
Adjourn
Sunday, May 17, 2026
8:00 AM
Coffee and Exhibits
8:30 AM
Program Chair Welcome
8:40 AM
Updates in Non-Prostate Cancer
Sandy Srinivas, MD | Stanford Medicine
9:00 AM
Updates in Prostate Cancer
Daniel Vaena, MD | West Cancer Center
9:20 AM
Panel Discussion and Q&A - Genitourinary Cancer
Brad Somer, MD (Moderator) | West Cancer Center
Daniel Vaena, MD | West Cancer Center
Sandy Srinivas, MD | Stanford Medicine
Holger Gieschen, MD | West Cancer Center
9:50 AM
Breakfast and Exhibits
10:05 AM
Non-CME Breakfast - SAGA Diagnostics - Structural Variant–Driven MRD in Breast Cancer: A New Paradigm from Diagnosis to Recurrence
Jason Carey, PhD | SAGA Diagnostics
10:50 AM
Where is AI going in Oncology?
Ravi Parikh, MD, MPP, FACP | Winship Cancer Institute
11:25 AM
Threats and Opportunities of IRA and MFN in Oncology
Barbara McAneny, MD | New Mexico Oncology Hematology Consultants
11:45 AM
Transitioning to Outpatient Bite Therapy
Jason Chandler, MD| West Cancer Center
12:05 PM
Lunch and Exhibits
12:20 PM
Non-CME Lunch - Pfizer - A Treatment Option for Adults with Certain R/R DLBCL After ≥2 Prior Lines of Systemic Therapy
Vincent Herrin, MD | University of Mississippi Medical Center
1:05 PM
Management of HER2 Low and HER2 Ultra Low
Gregory Vidal, MD, PhD | West Cancer Center
1:25 PM
Management HER2+
Amina Chaudhry, MD | Stanford Medicine
1:45 PM
Panel Discussion and Q&A - Breast Cancer
Darcey Eastwood, MD (Moderator) | West Cancer Center
Alyssa Pittman, MD | West Cancer Center
Gregory Vidal, MD, PhD | West Cancer Center
Amina Chaudhry, MD | Stanford Medicine
Noam Vanderwalde, MD | West Cancer Center
2:15 PM
Adjourn
Agenda Subject To Change. All times are CST.
-
Identify novel targeted and immunologic approaches to therapy for various cancers
Integrate recent findings on healthcare disparities into optimal therapy selection for individual patients with cancer
Identify optimal therapies for patients and managing and mitigating side effects
Describe findings from recent clinical trials evaluating immunotherapies
Identify strategies to prevent and manage the treatment related adverse events of targeted therapies and immunotherapies to improve tolerability and maintain quality of life
Foster discussions on equitable and equal access and delivery of care for disparate populations, including discussing research and drug and diagnostic pipeline development that include underserved and underrepresented patients
-
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 7.50 ANCC contact hours.Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 7.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 7.50 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
American Board of Internal Medicine (ABIM) MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.
-
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Enduring video content for watching at your leisure
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources
Catered meals through-out the program